KMT2A and leukemia: This work resulted in the compound MI-503 (table 1), which bound menin with a Kd of 9.3 nM and demonstrated anti-proliferative activity in MLL-r leukaemia cells in culture and tumour growth inhibition in mouse xenograft models.